sign in sign up
<<
Home , Klatskin tumor, Linitis plastica, Pancreatoblastoma

Reportable List 2021 REPORTING REQUIREMENTS (MINNESOTA RULES 4606.3302) All invasive and in situ and all benign and borderline brain and CNS . Refer to the ICD-O 3.2 and ICD-O 3rd Editions, the 2021 ICD-O-3.2 Coding Update Tables, the 2018 Coding Update Tables, the 2007 Multiple Primary & Histology Manual for 2007-2017 diagnoses, the 2018 Solid Tumor Rules Database for diagnoses 2018 & forward, the SEER Hematopoietic and Lymphoid Database when determining reportability. Note: Behavior codes and/or histology codes may have changed in 2021. Reportable diagnoses include, but are not limited to the following: Acoustic neuroma Craniopharyngioma Germ cell tumor Acute panmyelosis Cystic pancreatic endocrine neoplasm Germinoma Adamantinoma of long bones (CPEN) Heavy chain disease Adenocarcinofibroma Desmoplastic small round cell tumor Agnogenic myeloid metaplasia Dysgerminoma Hepatoma, embryonal, malignant, NOS Aggressive digital papillary Ectomesenchymoma Histiocytosis, malignant/Histiocytosis X, AIN III Endodermal sinus tumor Langerhans Askin tumor Endolymphatic stromal myosis Hutchinson melanotic freckle Atypical teratoid/rhabdoid tumor Endometrial stromatosis Hypereosinophilic syndrome Beta cell adenoma Endometroid intraepithelial neoplasm, Hypernephroma Blastoma grade III Immunoproliferative disease, NOS; small (except ECL NOS, strumal, Epitheloid trophoblastic tumor intestinal disease tubular) Epithelioma, malignant, certain types Intraductal papillary mucinous neoplasm , all types (except basal cell and (except basal cell and squamous cell of non- (ITPN) squamous cell of non-genital skin) genital skin) Intraepithelial neoplasia, grade lll (except Carotid body paraganglioma/tumor Ewing cervix and prostate) Chordoma Gastrointestinal stromal tumor (GIST) Kaposi sarcoma 202 1 REPORTING REQUIREMENTS

Klatskin tumor Melanoma/early/evolving, all types (except Polyembryoma juvenile) Precancerous melanosis, malignant Langerhans cell histiocytosis, disseminated Mesodermal mixed tumor melanoma in situ/early/evolving Laryngeal intraepithelial neoplasia, grade III (except cystic or benign) (LIN III) Mucinous cystic neoplasm of with Queyrat erythroplasia Letterer-Siwe disease high grade dysplasia (MCN) Rhabdoid tumor Mullerian mixed tumor/ Sarcoma, all types in situ (LCIS) Mycosis fungoides/pagetoid reticulosis Schwannoma, malignant and/or CNS Lobular neoplasia grade lll (LN III)/lobular Myeloproliferative disease/disorder Seminoma intraepithelial neoplasia grade III (LIN III) Myelosclerosis Sertoli-Leydig cell tumor, poorly Breast Nephroblastoma differentiated or sarcomatoid Lymphomatous polyposis, malignant Neuroblastoma Sezary syndrome/disease Lymphoproliferative disease of childhood, Neuroectodermal tumor (except melanotic) Solid pseudopapillary neoplasm of pancreas systemic EBV positive T-cell Paget disease (except bone) Spindle epithelial tumor with thymus-like Lymphoproliferative disorder, chronic of NK Pancreatic intraepithelial neoplasia (PanIN element cells; III) Spinal cord, all tumors Malignant tumor, all types (except Squamous intraepithelial neoplasia, grade malignant hydatidiform mole) Penile intraepithelial neoplasia, grade III III (SIN III, except cervix and skin) Mast cell disease, systemic tissue (PeIN III) Systemic mastocytosis Mature teratoma of the testes in adults Pineal , all tumors VAIN III/VIN III/VUIN III Medulloepithelioma Pituitary gland, all tumors Wilms tumor Plasmacytoma Yolk sac tumor

Reporting Requirements (Minnesota Rules 4606.3302) . Malignant and in situ neoplasms of all sites with behavior code of /2 or /3, except as noted in next section . Basal and squamous cell of the genitalia . All brain and central nervous system (CNS) neoplasms regardless of . Myeloproliferative and myelodysplastic disorders/neoplasms 2001 - forward . Hematopoietic/lymphoid malignancies 2010 and later listed in the SEER Hematopoietic and Lymphoid Neoplasm Database . With or without microscopic confirmation

2 202 1 REPORTING REQUIREMENTS

Diagnoses that are NOT Reportable . Intraepithelial neoplasia of cervix (CIN III) diagnosed before 1992 or after 1995 . Intraepithelial neoplasia of prostate (PIN III) . (Adeno)carcinoma in situ of the uterine cervix after 1995 . Basal and of the skin (except genitalia) . Borderline ovarian tumors diagnosed before 1992 or after 2000

List of Common Reportable Acronyms AIN Anal intraepithelial neoplasia (III only) PPNET Peripheral primitive neuroectodermal tumor BALT Bronchial-associated lymphoid tissue RA Refractory anemia CASTLE Carcinoma showing thymus-like element RAEB Refractory anemia with excess blasts CPNET Central primitive neuroectodermal tumor RAEB-T Refractory anemia with excess blasts in transformation DCIS in situ RARS Refractory anemia with ringed sideroblasts GISS Gastrointestinal stromal sarcoma SALT Skin-associated lymphoid tissue GIST Gastrointestinal stromal tumor SETTLE Spindle epithelial neoplasia tumor with thymus like LCIS Lobular carcinoma in situ differentiation/element LIN Laryngeal intraepithelial neoplasia (III only) SIN Squamous intraepithelial neoplasia (III only) MALT Mucosa-associated lymphoid tissue VIN/VAIN Vulvar/Vaginal intraepithelial neoplasia (III only) MPNST Malignant peripheral nerve sheath tumor VUIN Vulvar intraepithelial neoplasia (III only) PNET Primitive neuroectodermal tumor Qualifier List and Ambiguous Terminology for Reportability (Case Finding only Not Histology Coding) - Refer to the SEER Program Coding and Staging Manual for case finding Ambiguous Terms and guidelines. Reportable Qualifiers/Ambiguous Terms for Case Finding . Presumed . Apparently/Appears . Probable . Comparable/Compatible/Consistent with . Suspect(ed) . Favor(s) . Suspicious for (histology, peripheral smear, etc. except . Malignant appearing cytology) . Most Likely . Typical (of)

3 202 1 REPORTING REQUIREMENTS

Not Reportable Qualifiers/Ambiguous Terms for case finding . Potentially malignant includes, but are not limited to the following . Questionable . Approaching . Rule Out . Borderline . Suggests . Cannot be excluded . Suspicious but not diagnostic of . Cannot be ruled out . Suspicious (cytology only) . Concerning for . Very close to . Equivocal . Worrisome . Possible

Ambiguous Terminology for Coding Histology

- Refer to the Solid Tumor Rules Manual, page 12 for coding histology using ambiguous terminology. Ambiguous terms are also listed in each of the site-specific chapters. NOTE: ICD-O-3.1 has never been approved for use in North America. NOTE: ICD-O-3.2 is approved for use in North America beginning with 1/1/2021 diagnoses. It is available in excel format only at https://www.naaccr.org/icdo3/

Minnesota Department of Health Minnesota Reporting System 85 East 7th Place PO Box 64882 St. Paul, MN 55164-0882 651-201-5900 [email protected] www.health.state.mn.us

To obtain this information in a different format, call: 651-201-5900. Printed on recycled paper.

4